Characterization of a Distinct State in the Continuum of Pluripotency Facilitated by Inhibition of PKCζ in Mouse Embryonic Stem Cells

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2023 Feb 13

PMID 36781773

Authors

Ishita Baral

Mayur Balkrishna Shirude

Dhana Lakshmi Jothi

Ananda Mukherjee

Debasree Dutta

Affiliations

Soon will be listed here.

Abstract

Inhibition of PKC (PKCi) signaling maintains pluripotency of embryonic stem cells (ESCs) across different mammalian species. However, the position of PKCi maintained ESCs in the pluripotency continuum is largely unknown. Here we demonstrate that mouse ESCs when cultured continuously, with PKCi, for 75 days are retained in naïve state of pluripotency. Gene expression analysis and proteomics studies demonstrated enhanced naïve character of PKCi maintained ESCs in comparison to classical serum/LIF (S/L) supported ESCs. Molecular analysis revealed that activation of PKCζ isoform associate with primed state of pluripotency, present in epiblast-like stem cells generated in vitro while inhibition of PKCζ phosphorylation associated with naïve state of pluripotency in vitro and in vivo. Phosphoproteomics and chromatin modification enzyme array based studies showed loss in DNA methyl transferase 3B (DNMT3B) and its phosphorylation level upon functional inhibition of PKCζ as one of the crucial components of this regulatory pathway. Unlike ground state of pluripotency maintained by MEK/GSK3 inhibitor in addition to LIF (2i/LIF), loss in DNMT3B is a reversible phenomenon in PKCi maintained ESCs. Absence of phosphorylation of c-MYC, RAF1, SPRY4 while presence of ERF, DUSP6, CIC and YAP1 phosphorylation underlined the phosphoproteomics signature of PKCi mediated maintenance of naïve pluripotency. States of pluripotency represent the developmental continuum and the existence of PKCi mediated mouse ESCs in a distinct state in the continuum of pluripotency (DiSCo) might contribute to the establishment of stages of murine embryonic development that were non-permissible till date.

References

Evans M, Kaufman M . Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981; 292(5819):154-6. DOI: 10.1038/292154a0. View

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

Brons I, Smithers L, Trotter M, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes S . Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007; 448(7150):191-5. DOI: 10.1038/nature05950. View

Tesar P, Chenoweth J, Brook F, Davies T, Evans E, Mack D . New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature. 2007; 448(7150):196-9. DOI: 10.1038/nature05972. View

Nichols J, Smith A . Naive and primed pluripotent states. Cell Stem Cell. 2009; 4(6):487-92. DOI: 10.1016/j.stem.2009.05.015. View

Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y . Germline competent embryonic stem cells derived from rat blastocysts. Cell. 2008; 135(7):1299-310. PMC: 2735113. DOI: 10.1016/j.cell.2008.12.006. View

Ying Q, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J . The ground state of embryonic stem cell self-renewal. Nature. 2008; 453(7194):519-23. PMC: 5328678. DOI: 10.1038/nature06968. View

Wray J, Kalkan T, Smith A . The ground state of pluripotency. Biochem Soc Trans. 2010; 38(4):1027-32. DOI: 10.1042/BST0381027. View

Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H . The transcriptional and epigenomic foundations of ground state pluripotency. Cell. 2012; 149(3):590-604. PMC: 3398752. DOI: 10.1016/j.cell.2012.03.026. View

10.

Guo G, Pinello L, Han X, Lai S, Shen L, Lin T . Serum-Based Culture Conditions Provoke Gene Expression Variability in Mouse Embryonic Stem Cells as Revealed by Single-Cell Analysis. Cell Rep. 2016; 14(4):956-965. PMC: 4740311. DOI: 10.1016/j.celrep.2015.12.089. View

11.

Dutta D, Ray S, Home P, Larson M, Wolfe M, Paul S . Self-renewal versus lineage commitment of embryonic stem cells: protein kinase C signaling shifts the balance. Stem Cells. 2011; 29(4):618-28. PMC: 3413330. DOI: 10.1002/stem.605. View

12.

Rajendran G, Dutta D, Hong J, Paul A, Saha B, Mahato B . Inhibition of protein kinase C signaling maintains rat embryonic stem cell pluripotency. J Biol Chem. 2013; 288(34):24351-62. PMC: 3750137. DOI: 10.1074/jbc.M113.455725. View

13.

Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F . Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell. 2014; 158(6):1254-1269. PMC: 4162745. DOI: 10.1016/j.cell.2014.08.029. View

14.

Baral I, Varghese P, Dutta D . Epigenetics as "conductor" in "orchestra" of pluripotent states. Cell Tissue Res. 2022; 390(2):141-172. DOI: 10.1007/s00441-022-03667-0. View

15.

Acampora D, Di Giovannantonio L, Simeone A . Otx2 is an intrinsic determinant of the embryonic stem cell state and is required for transition to a stable epiblast stem cell condition. Development. 2012; 140(1):43-55. DOI: 10.1242/dev.085290. View

16.

Syed K, Joseph S, Mukherjee A, Majumder A, Teixeira J, Dutta D . Histone chaperone APLF regulates induction of pluripotency in murine fibroblasts. J Cell Sci. 2016; 129(24):4576-4591. PMC: 5201018. DOI: 10.1242/jcs.194035. View

17.

Majumder A, Syed K, Joseph S, Scambler P, Dutta D . Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1. J Biol Chem. 2015; 290(21):13053-63. PMC: 4505562. DOI: 10.1074/jbc.M114.615492. View

18.

Varghese P, Rajam S, Nandy D, Jory A, Mukherjee A, Dutta D . Histone chaperone APLF level dictates the implantation of mouse embryos. J Cell Sci. 2020; 134(1). DOI: 10.1242/jcs.246900. View

19.

Sherman B, Hao M, Qiu J, Jiao X, Baseler M, Lane H . DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022; 50(W1):W216-W221. PMC: 9252805. DOI: 10.1093/nar/gkac194. View

20.

Kramer A, Green J, Pollard Jr J, Tugendreich S . Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2013; 30(4):523-30. PMC: 3928520. DOI: 10.1093/bioinformatics/btt703. View